Department of Cardiology, The First Medical Center, Chinese PLA General Hospital, Beijing, China.
7th Department of Health Cadre, The Second Medical Center, Chinese PLA General Hospital, Beijing, China.
ESC Heart Fail. 2024 Oct;11(5):2778-2788. doi: 10.1002/ehf2.14795. Epub 2024 May 15.
The Selvester scoring system has been derived from ECG parameters for estimating infarct size. However, there is still a lack of evidence for Selvester score as an alternative to cardiac magnetic resonance (CMR) myocardial injury makers for risk stratification and prediction of left ventricular function (LVF) recovery among patients with ST-segment elevation myocardial infarction (STEMI).
This multicentre observational study enrolled 328 STEMI patients (88.4% men, 57.3 ± 10.6 years of age) undergoing CMR examination 1 week post-reperfusion therapy. Patients with baseline left ventricular ejection fraction (LVEF) < 50% underwent a follow-up CMR 6 months later, categorized into baseline normal LVF (ejection fraction [EF] ≥ 50% at baseline, n = 155); recovered LVF (EF < 50% at baseline and ≥50% after 6 months, n = 69); and reduced LVF (EF < 50% at baseline and after 6 months, n = 104). The median follow-up was 4 (3-4) years for all patients, with 61 patients experiencing major adverse cardiovascular event (MACEs). Patients with reduced LVF had a higher risk of MACEs than those with baseline normal LVF (P = 0.01), while the recovered LVF group had no significant difference (P > 0.05). A Selvester score >10 doubled the risk of MACEs in patients with systolic dysfunction (1.91 [1.02 to 3.58], P = 0.04). Additionally, Selvester score, baseline LVEF, transmural infarction, and peak CK-MB were independent predictors of recovered LVF, with Selvester score providing incremental predictive value to peak CK-MB in predicting recovered LVF (∆AUC = 0.07, P < 0.05).
The Selvester score improves risk stratification among STEMI patients beyond LVEF and provide independent and incremental information to clinical parameters in predicting recovered LVF.
塞尔维斯特评分系统源自心电图参数,用于估算梗死面积。然而,塞尔维斯特评分作为 ST 段抬高型心肌梗死(STEMI)患者风险分层和左心室功能(LVF)恢复预测的替代心脏磁共振(CMR)心肌损伤标志物,仍缺乏证据支持。
本多中心观察性研究纳入了 328 例 STEMI 患者(88.4%为男性,年龄 57.3±10.6 岁),这些患者在再灌注治疗后 1 周接受 CMR 检查。基线左心室射血分数(LVEF)<50%的患者在 6 个月后进行了随访 CMR,根据基线 LVEF 将患者分为:基线正常 LVEF(基线时 EF≥50%,n=155);恢复 LVEF(基线时 EF<50%,但 6 个月后≥50%,n=69);和低 LVEF(基线时 EF<50%,且 6 个月后仍<50%,n=104)。所有患者的中位随访时间为 4(3-4)年,有 61 例患者发生重大不良心血管事件(MACEs)。低 LVEF 患者的 MACEs 风险高于基线正常 LVEF 患者(P=0.01),而恢复 LVEF 组无显著差异(P>0.05)。在有收缩功能障碍的患者中,塞尔维斯特评分>10 使 MACEs 的风险增加一倍(1.91[1.02 至 3.58],P=0.04)。此外,塞尔维斯特评分、基线 LVEF、透壁性梗死和峰值 CK-MB 是恢复 LVEF 的独立预测因子,塞尔维斯特评分在预测恢复 LVEF 方面提供了比峰值 CK-MB 更高的增量预测值(∆AUC=0.07,P<0.05)。
塞尔维斯特评分可提高 STEMI 患者的风险分层能力,超越 LVEF,并为预测恢复 LVEF 提供独立且有增量价值的临床参数信息。